ACTRIMS ® 2025 Abstracts Are Out! 🚀 Continuing our coverage of #ACTRIMS 2025, here are some key abstracts shaping the future of MS care: ➡️ Ocrelizumab (OCARINA II): Subcutaneous administration—what do patients prefer? ➡️ Fenebrutinib (FENopta): Can it maintain low disease activity in relapsing MS? ➡️ CD19 CAR T Therapies: KYV-101 & BMS-986353—next-gen approaches for progressive MS. ➡️ Ocrelizumab (CONSONANCE): Four-year data on primary & secondary progressive MS. ➡️ Ublituximab (ENHANCE): 30-minute infusions—how safe and tolerable are they? ➡️ Ofatumumab (EAFToS II): Real-world insights into patient outcomes. Want deeper insights or customized coverage? Reach out to our DataZymes team! 📩 DM Rishi Srivastava, Mamtha Aras, or Divya Singh to explore how we can support your MS research and development efforts. #ACTRIMS2025 #MSResearch #Biopharma #Neurology #NeuroSciences #Pharma #MultipleSclerosis #Consulting #CompetitiveIntelligence
DataZymes
Business Consulting and Services
Philadelphia, PA 16,602 followers
Catalyzing Innovation
About us
Catalyzing Innovation in Pharma with Data-driven Digital Products. The idea of DataZymes germinated with the realization that Pharma Commercial teams had few alternatives to the antiquated and inefficient solutions offered by traditional consulting and technology companies. Already a laggard in analytical maturity, the Pharma industry had been facing challenges to adapt to a Big Data world. We saw that the products offered by technology companies were too rigid and generic to handle novel problems. The custom solutions offered by consulting organizations took too long to deploy and required many services to maintain and improve. We felt the need for a different approach to finding solutions and we knew it would take a different kind of company to build it. That’s why DataZymes. We’re focused on creating the world’s best user experience for working with data, one that empowers people to ask and answer complex questions without requiring them to master querying languages, statistical modeling, or the command line. To achieve this, we are building platforms for integrating, managing, and securing data on top of which we layer applications for fully interactive machine-driven, human-assisted analysis.
- Website
-
https://datazymes.com/
External link for DataZymes
- Industry
- Business Consulting and Services
- Company size
- 51-200 employees
- Headquarters
- Philadelphia, PA
- Type
- Privately Held
- Founded
- 2016
- Specialties
- Marketing Analytics, Sales Analytics, Payer Analytics, Access Analytics, Patient Analytics, Pharma, Data Solutions, Specialty Data, Pharmaceuticals, Data Quality, Competitive Intelligence, Forecasting, Market Assessments, LifeSciences, Analytics, US Pharma, Data Management, and Data Engineering
Locations
-
Primary
500 Office Center Dr.
Suite 400
Philadelphia, PA 19034, US
-
A-130, A Block, Sector 63,
Noida, UP 201301, IN
-
HoneyKomb by Bhive, Primrose Road
Bengaluru, Karnataka 560025, IN
Employees at DataZymes
Updates
-
🌟 Join Datazymes at ACTRIMS Forum 2025! 🌟 Breakthroughs in remyelination research are redefining the future of Multiple Sclerosis (MS) care. For biopharma leaders, staying ahead means harnessing cutting-edge science, collaborating with top experts, and leveraging data-driven clinical insights. We are excited to be at Americas Committee for Treatment & Research in Multiple Sclerosis (ACTRIMS) Forum 2025—a key event driving innovation in MS research. 📅 Event Details: 🗓 Date: February 27 – March 1, 2025 📍 Location: West Palm Beach, Florida 🔬 What’s Next in MS Research? ✅ Remyelination advancements – The science behind repairing MS damage ✅ New strategies vs. past challenges – What’s working and why ✅ Transforming MS drug development – The latest clinical and biomarker insights As a trusted consulting partner for biopharma, Datazymes empowers organizations with cutting-edge analytics, AI-driven insights, and strategic expertise—helping you accelerate innovation and bring life-changing therapies to patients faster. 🔗 Let’s collaborate! DM us (Rishi Srivastava, Mamtha Aras, Divya Singh) to schedule a meeting and explore how Datazymes can help drive your MS research forward. #ACTRIMS25 #Biopharma #MultipleSclerosis #Neuroscience #Remyelination #HealthcareInnovation #MSResearch #Consulting #StrategicInsights #CompetitiveIntelligence
-
Immunology: Shaping the Future of Healthcare Immunology, the cornerstone of biomedical science, explores the intricate mechanisms of the immune system, revealing how our bodies defend against diseases. As groundbreaking therapies emerge and the pursuit of addressing unmet medical needs continues, the field has experienced remarkable growth in recent years. International conferences provide invaluable platforms for pharma leaders, scientists, competitive intelligence professionals, and key stakeholders to navigate the evolving treatment landscape. These gatherings ignite insightful discussions, foster meaningful collaborations, and play a pivotal role in driving future immunological breakthroughs. ✨ We’re excited to share the comprehensive list of upcoming international immunology conferences for 2025! Join us to connect, exchange knowledge, and contribute to pioneering solutions that will shape the future of immunology. We look forward to engaging in enriching discussions that will inspire innovation and drive progress forward. 📧 Have questions about conference coverage or competitive intelligence? Reach out to us at contact@datazymes.com. 💡 Stay tuned for updates on global immunology events in 2025—plan ahead and seize these incredible opportunities! Let’s collaborate and make a lasting impact on the future of immunology. #Immunology2025 #PharmaConferences #InnovationInImmunology #Datazymes #competitiveintelligence #conferences
-
Today, as we mark the 76th Republic Day of India, let's take a moment to honor the values of democracy, freedom, and unity that our nation stands for. DataZymes and the team wishes everyone a very Happy Republic Day! Let's continue working together to build a future that’s inclusive, sustainable, and prosperous for all. Jai Hind. #RepublicDay #Bharat#India#Democracy
-
-
🌟 Exciting News: Strengthening Our Leadership Team! We are thrilled to announce that Harsha V., who has been collaborating with us over the past couple of years, is officially joining our leadership team to further strengthen our focus on AI in Pharma. As a trusted advisor, Harsha has been instrumental in fine-tuning many of our solution offerings and enhancing our products, leaving a lasting impact on our company’s growth and innovation trajectory. Expanding our relationship was a natural next step, and we couldn’t be more excited to have him bring his vision, expertise, and leadership to this next phase of our journey. Harsha is a seasoned Decision Science & Pharma Commercial Analytics Leader with over 25 years of experience. He has a proven track record of building and leading enterprise-wide Insights & Analytics functions powered by high-performing talent, efficient processes, and cutting-edge capabilities in top-tier pharmaceutical organizations, including AZ and GSK, across both U.S. and global roles. Please join us in welcoming Harsha to the team as we continue to drive innovation and build towards an AI-powered future in Pharma! 🎉 #Leadership #WelcomeToTheTeam #StrategicGrowth #Innovation #AIinPharma
-
-
On this vibrant festival of harvest and new beginnings, let’s embrace the opportunities ahead with optimism and determination. May your path be filled with success and your goals soar high like the kites in the sky. Here’s to new challenges, growth, and brighter horizons. Best wishes to everyone from Team DataZymes! #NewBeginnings #Prosperity #Growth #Success
-
-
DataZymes reposted this
The Countdown Begins: JPM HealthcareConference 2025 The 43rd Annual J.P. Morgan Healthcare Conference (JPM) will be held in San Francisco, CA, from January 13 - 16, 2025, and we are thrilled to participate in the conversation shaping the future of healthcare. As one of the most influential events in biotech and life sciences, #JPM2025 is where innovation meets investment and strategy transforms into breakthroughs. Here’s what our DataZymes Competitive Intelligence (#CI) team will be focusing on during this jam-packed week: ✅ Biopharma Leaders – Insights on pipeline updates, strategic priorities, and clinical milestones. ✅ Emerging Biotech Companies – Breakthroughs from startups transforming the healthcare landscape. ✅ Industry Trends – Key themes in investments, M&A, and market dynamics. ✅ Technology Highlights – Advances in AI, cell & gene therapies, and digital health. (Our experts— Mamtha Aras, Divya Singh, Bindu Malhotra Vasanthi Tirumala, Sravanthi Bandaru and Suraj S—will be your eyes and ears at the conference!) 📌 We’ve curated a list of must-watch sessions to guide you through the conference, ensuring you don’t miss a moment of the biggest healthcare investor event of the year. 💬 What are you most excited about at #JPM2025? Let us know in the comments or reach out to us at contact@datazymes.com for insights, support, or a conversation about the latest industry trends. #HealthcareInnovation #CompetitiveIntelligence #JPMConference #Biotech #Pharma #LifeSciences #immunology #oncology #neuroscience
-
The Countdown Begins: JPM HealthcareConference 2025 The 43rd Annual J.P. Morgan Healthcare Conference (JPM) will be held in San Francisco, CA, from January 13 - 16, 2025, and we are thrilled to participate in the conversation shaping the future of healthcare. As one of the most influential events in biotech and life sciences, #JPM2025 is where innovation meets investment and strategy transforms into breakthroughs. Here’s what our DataZymes Competitive Intelligence (#CI) team will be focusing on during this jam-packed week: ✅ Biopharma Leaders – Insights on pipeline updates, strategic priorities, and clinical milestones. ✅ Emerging Biotech Companies – Breakthroughs from startups transforming the healthcare landscape. ✅ Industry Trends – Key themes in investments, M&A, and market dynamics. ✅ Technology Highlights – Advances in AI, cell & gene therapies, and digital health. (Our experts— Mamtha Aras, Divya Singh, Bindu Malhotra Vasanthi Tirumala, Sravanthi Bandaru and Suraj S—will be your eyes and ears at the conference!) 📌 We’ve curated a list of must-watch sessions to guide you through the conference, ensuring you don’t miss a moment of the biggest healthcare investor event of the year. 💬 What are you most excited about at #JPM2025? Let us know in the comments or reach out to us at contact@datazymes.com for insights, support, or a conversation about the latest industry trends. #HealthcareInnovation #CompetitiveIntelligence #JPMConference #Biotech #Pharma #LifeSciences #immunology #oncology #neuroscience
-
Wishing you all a Merry Christmas 🎄 and a Happy New Year 🎆! May this festive season bring you more joy, peace, and success. Here's to new opportunities, growth, and exciting adventures in the year ahead! 🎉 #MerryChristmas #NewYear2025 #NewBeginnings #TogetherInGrowth #DataZymes
-
🎄This Christmas at DataZymes was filled with joy, surprises, and togetherness! From exciting games to surprise gifts, we celebrated the spirit of the season with enthusiasm and cheer. Here's to creating more such memorable moments with our incredible team! ✨🎁 #ChristmasCelebration #TeamDataZymes #WorkplaceFun